Cargando…

Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care

SIMPLE SUMMARY: Historically, patients with pancreatic ductal adenoma carcinoma were subjected to immediate surgical resection of the pancreatic tumor. Nowadays, more and more patients are treated with chemo(radio)therapy before surgical resection. It is known that patients with pancreatic cancer ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willems, R. A. L., Michiels, N., Lanting, V. R., Bouwense, S., van den Broek, B. L. J., Graus, M., Klok, F. A., Groot Koerkamp, B., de Laat, B., Roest, M., Wilmink, J. W., van Es, N., Mieog, J. S. D., ten Cate, H., de Vos-Geelen, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376958/ https://www.ncbi.nlm.nih.gov/pubmed/37509209 http://dx.doi.org/10.3390/cancers15143546

Ejemplares similares

Is delaying pharmacological thromboprophylaxis associated with thromboembolic complications?
por: Padim, P, et al.
Publicado: (2015)

Outcomes following pancreatic surgery using three different thromboprophylaxis regimens
por: Hanna‐Sawires, R. G., et al.
Publicado: (2019)

Is thromboprophylaxis effective in reducing the pulmonary thromboembolism?
por: Rajabi, Fereshteh, et al.
Publicado: (2012)

Increased Risk for Thromboembolism After Fontan Surgery: Considerations for Thromboprophylaxis
por: Van Den Helm, Suelyn, et al.
Publicado: (2022)

Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis
por: Minet, Clémence, et al.
Publicado: (2015)

Thromboprophylaxis for venous thromboembolism prevention in hip fracture patients
Publicado: (2017)

Coronavirus disease 2019 in pregnancy: consider thromboembolic disorders and thromboprophylaxis
por: Di Renzo, Gian Carlo, et al.
Publicado: (2020)

Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis
por: Schiaffino, Simone, et al.
Publicado: (2021)

ThromboprophylaXIs with Factor XI/XIa inhibitors for venous thromboembolism
por: Porres-Aguilar, Mateo
Publicado: (2023)

Reducing the burden of venous thromboembolism in the acute medically ill population with extended-duration thromboprophylaxis
por: Ageno, Walter, et al.
Publicado: (2018)

Does thromboprophylaxis prevent venous thromboembolism after major orthopedic surgery?,
por: Akpinar, Evrim Eylem, et al.
Publicado: (2013)

Thromboembolic risk factors and thromboprophylaxis in a medical–surgical ICU in Mexico
por: Perez-Rada, FJ, et al.
Publicado: (2009)

Incidence of Venous Thromboembolism in Hospitalized COVID-19 Patients Receiving Thromboprophylaxis
por: Huang, Jimmy, et al.
Publicado: (2022)

Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?
por: Mulder, Frits I., et al.
Publicado: (2020)

Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment
por: Aryal, Madan Raj, et al.
Publicado: (2020)

Thromboembolic Disease in Haemophilic Patients Undergoing Major Orthopaedic Surgery: Is Thromboprophylaxis Mandatory?
por: Badulescu, Oana Viola, et al.
Publicado: (2022)

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
por: Amin, A., et al.
Publicado: (2009)

Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma
por: de Jong, Evelien J. M., et al.
Publicado: (2021)

The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery
por: Gao, Yuan, et al.
Publicado: (2016)

Awareness of venous thromboembolism and thromboprophylaxis among hospitalized patients: a cross-sectional study
por: Almodaimegh, Hind, et al.
Publicado: (2017)

Analysis of Adherence to Thromboprophylaxis and Incidence of Venous Thromboembolism After Lower Limb Orthopaedic Surgery
por: Benjamin, Miles W, et al.
Publicado: (2021)

Thromboembolic complications during and after hospitalization for COVID-19: Incidence, risk factors and thromboprophylaxis
por: Tholin, Birgitte, et al.
Publicado: (2022)

Venous Thromboembolism Among Hospitalized Patients: Incidence and Adequacy of Thromboprophylaxis – A Retrospective Study
por: Ambra, Naseem, et al.
Publicado: (2022)

High level of venous thromboembolism in critically ill trauma patients despite early and well-driven thromboprophylaxis protocol
por: Hamada, S. R., et al.
Publicado: (2017)

Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia
por: Sun, Siyu, et al.
Publicado: (2021)

Treatment and Survival of Elderly Patients with Stage I–II Pancreatic Cancer: A Report of the EURECCA Pancreas Consortium
por: Groen, Jesse V., et al.
Publicado: (2020)

Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis
por: Chi, Gerald, et al.
Publicado: (2020)

Highlights: burden of venous thromboembolism and role of extended-duration thromboprophylaxis in acute medically ill patients
Publicado: (2018)

Venous Thromboembolism Risk and Thromboprophylaxis Assessment in Surgical Patients Based on Caprini Risk Assessment Model
por: Tadesse, Tamrat Assefa, et al.
Publicado: (2020)

Thromboembolic events in COVID-19 ambulatory patients: An observational study about incidence, and thromboprophylaxis outcomes
por: Hammami, Rania, et al.
Publicado: (2022)

Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer
por: Graus, Merlijn U.J.E., et al.
Publicado: (2023)

Venous Thromboprophylaxis in Spine Surgery
por: Alvarado, Anthony M., et al.
Publicado: (2019)

Chronic thromboembolic pulmonary hypertension
por: Schölzel, B. E., et al.
Publicado: (2014)

The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines
por: Alsubaie, Norah S., et al.
Publicado: (2021)

Increasing Systemic Immune-inflammation Index During Treatment in Patients With Advanced Pancreatic Cancer is Associated With Poor Survival: A Retrospective, Multicenter, Cohort Study
por: van ‘t Land, Freek R., et al.
Publicado: (2023)

Meta‐analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
por: Versteijne, E., et al.
Publicado: (2018)

Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)
por: van Haalen, F. M., et al.
Publicado: (2022)

Risk assessment of venous thromboembolism and thromboprophylaxis in pregnant women hospitalized with cancer: Preliminary results from a risk score
por: Hase, Eliane Azeka, et al.
Publicado: (2018)

Thromboprophylaxis and mortality among patients who developed venous thromboembolism in seven major hospitals in Saudi Arabia
por: Al-Hameed, Fahad M., et al.
Publicado: (2017)

The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
por: Zhang, Chuanlin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iemf0fbsj4trn9pr70a47bqk7k